IK
Live price temporarily unavailable.
Inhibikase Therapeutics Inc (IKT) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: December 23, 2020 · $10.00 offering · NASDAQ · View IPO details →
Recent News (6)
-
Universal Music Group and TikTok renew agreement to combat unauthorized AI music For years, UMG has pushed platforms, streaming services, and AI companies to implement stricter content moderation policies.
-
Mother of boy who may have died in TikTok challenge urges No 10 to ban social media
Ellen Roome, whose son, Jools Sweeney, was 14 when he died, wants a ban put in place for under-16s
The mother of a teenager who believes he died in a TikTok challenge gone wrong has said Downing Stree…
-
What is the impact of TikTok Shop on European Retail one year since launch What is the impact of TikTok Shop on European Retail one year since launch
-
TikTok and YouTube 'not safe enough' for kids, says Ofcom
YouTube said it worked with experts to provide appropriate experiences. TikTok said it was disappointed Ofcom had not acknowledged its safety features.
-
TikTok and YouTube 'not safe enough' for kids, says Ofcom
YouTube said it worked with experts to provide appropriate experiences. TikTok said it was disappointed Ofcom had not acknowledged its safety features.
-
TikTok star charged in LA murder-for-hire plot targeting boy band singer A social media influencer, her father and one-time boyfriend have been charged in a murder-for-hire plot targeting a popular singer who she shares a child with.